StemCell Institute (TSE:7096) Institutional Ownership: 2.70% (As of Aug. 16, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSE:7096 StemCell Institute TSE:7096
69 GF Score
Price 円757.00
GF Value 円1,831.68
Valuation Possible Value Trap
! 5 Warning Signs
View Full Analysis

What is StemCell Institute Institutional Ownership?

StemCell Institute TSE:7096 +2.44% 69 Institutional Ownership is 2.70% as of Aug. 16, 2026. GuruFocus rates TSE:7096 with a GF Score™ of 69/100 and a GF Value™ of 円1,831.68 (Possible Value Trap). The stock has 5 warning signs investors should review.

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, StemCell Institute's institutional ownership is 2.70%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, StemCell Institute's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, StemCell Institute's Float Percentage Of Total Shares Outstanding is 0.00%.

StemCell Institute Institutional Ownership Historical Data

* Premium members only.

The historical data trend for StemCell Institute's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

StemCell Institute Institutional Ownership Chart

StemCell Institute Historical Data

The historical data trend for StemCell Institute can be seen below:

2025-10-31 2025-11-30 2025-12-31 2026-01-31 2026-02-28 2026-03-31 2026-04-30 2026-05-31 2026-06-30 2026-07-31
Institutional Ownership 2.73 2.73 2.73 2.72 2.72 2.71 2.71 2.71 2.71 2.70
TSE:7096
69GF Score
StemCell Institute TSE:7096
Institutional Ownership is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

StemCell Institute Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.

What does a Institutional Ownership of 2.70% mean?
StemCell Institute (TSE:7096) has a Institutional Ownership of 2.70% as of Aug. 16, 2026. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on StemCell Institute and its competitors.
Is StemCell Institute's Institutional Ownership too high?
StemCell Institute's current Institutional Ownership is 2.70%. Overall, StemCell Institute has a GF Score™ of 69/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does StemCell Institute's Institutional Ownership compare to VRTX and REGN?
StemCell Institute's Institutional Ownership of 2.70% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Institutional Ownership for a Biotechnology company?
A good Institutional Ownership depends on the Biotechnology industry context. However, Institutional Ownership should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Institutional Ownership mean?
A high Institutional Ownership can signal that a stock is expensive relative to its fundamentals. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on StemCell Institute and its competitors. StemCell Institute's current Institutional Ownership is 2.70%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is StemCell Institute stock overvalued right now?
Based on GuruFocus' analysis, StemCell Institute (TSE:7096) is currently considered Possible Value Trap. The stock's GF Value™ is 円1,831.68, compared to a current price of 円757.00 — trading 58.7% below its estimated fair value. The current Institutional Ownership is 2.70%. StemCell Institute's overall GF Score™ is 69/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Institutional Ownership calculated?
Institutional Ownership is calculated from a company's financial statements. For StemCell Institute (TSE:7096), the current Institutional Ownership is 2.70% as of Aug. 16, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is StemCell Institute (TSE:7096) Overvalued in 2026?

Based on GuruFocus' analysis, StemCell Institute stock appears to be undervalued. The current stock price of 円757.00 is trading 58.7% below its estimated GF Value™ of 円1,831.68. GuruFocus considers StemCell Institute to be Possible Value Trap.

Key valuation signals for TSE:7096:

  • Institutional Ownership: 2.70%
  • GF Value™: 円1,831.68 vs. price of 円757.00 (58.7% below fair value)
  • GF Score™: 69/100 with 5 warning signs

No single metric tells the full story. See the TSE:7096 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

StemCell Institute Business Description

Address 1-21-19 Toranomon, Minato-ku, Tokyo, JPN, 105-0001
StemCell Institute is engaged in the Cell bank business that separates and stores cord blood for regenerative medicine. Cord blood is the baby's blood contained in the umbilical cord and placenta that connects the mother and baby. In its umbilical cord blood storage business, upon receiving notification from customers who have contracted, umbilical cord blood collected at obstetric facilities throughout Japan is collected, transported to the company's cell processing center within 48 hours, and it provides a service to store cells at ultra-low temperature after separating cells from blood. The Company operates in a single segment, the cell bank business sales consist of three components: technical fees, storage fees, and other fees.
69GF Score

Get the complete analysis for TSE:7096

Institutional Ownership is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円757.00
Price
円1,831.68
GF Value